James Baumgardner is a Senior PhD Research Economist at Precision Health Economics (PHE) and an expert in health economics and policy. He joined PHE after a number of years at the Congressional Budget Office (CBO). Dr. Baumgardner held leadership positions for most of his 20 years at the CBO, providing information to guide legislative initiatives affecting Medicare, the regulation of employment-based and individually purchased health plans, graduate medical education, the costs of insurance coverage, health improvements in the population, and Medicare’s prescription drug program. Prior to his time at the CBO, Dr. Baumgardner was an Assistant Professor of Economics at Duke University. His publications include a number of CBO reports and papers appearing in the New England Journal of Medicine, Journal of Political Economy, RAND Journal of Economics, Inquiry, and the American Economic Review. Dr. Baumgardner received his AB in economics (with honors) from Duke University and his PhD in economics from the University of Chicago.
Recent Posts by James R. Baumgardner
While CEAs of pharmaceutical interventions are vital, the disproportionate application of CEA to certain types of interventions can lead to less efficient use of health care dollars overall.